Meta-Analysis
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 21, 2014; 20(47): 18001-18012
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.18001
Figure 2
Figure 2 Forest plots of the effects of gemcitabine-based combination chemotherapy in patients with biliary tract cancer. A: Disease response rate; B: Disease control rate; C: Progression-free survival; D: Overall survival. Gem: Gemcitabine monotherapy; Gem-based: Gem-based combination chemotherapy; non-Gem-based: non-Gemcitabine-based chemotherapy.